News Sentiment

INMB sentiment intelligence

INmune Bio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 35 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.94 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 27

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+14.1% over one week, +56.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction 14.1% Price confirming higher
Trend fit Trend inactive 56.5% over four weeks
Fair value -67.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 26
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 27
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 8
Market source 6
GlobeNewswire 5
MT Newswires 4
simplywall.st 4
TradingKey 1
Investing.com Nigeria 1
Ad Hoc News 1

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 10
Regulatory and legal 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 35